The effect of granulocyte and monocyte adsorptive apheresis on serum cytokine levels in patients with ulcerative colitis

被引:22
|
作者
Toya, Yosuke [1 ]
Chiba, Toshimi [1 ]
Mizutani, Tomomi [1 ]
Sato, Kunihiko [1 ]
Kasugai, Satoshi [1 ]
Matsuda, Nozomi [1 ]
Orikasa, Shunsuke [1 ]
Shibata, Sho [1 ]
Abiko, Yukito [1 ]
Akasaka, Risaburo [1 ]
Yokoyama, Naoki [1 ]
Oana, Shuhei [1 ]
Hirota, Shigeru [1 ]
Endo, Masaki [1 ]
Suzuki, Kazuyuki [1 ]
机构
[1] Iwate Med Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med, Morioka, Iwate 0208505, Japan
关键词
Ulcerative colitis; Granulocyte and monocyte adsorptive apheresis; GMA; Cytokine levels; Interleukin-10; INFLAMMATORY-BOWEL-DISEASE; REFRACTORY CROHNS-DISEASE; POLYMORPHONUCLEAR NEUTROPHILS; SELECTIVE LEUKOCYTAPHERESIS; INTESTINAL INFLAMMATION; INDUCIBLE PROTEIN-10; T-CELLS; ADACOLUMN; EFFICACY; THERAPY;
D O I
10.1016/j.cyto.2013.01.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Granulocyte and monocyte adsorptive apheresis (GMA) with an Adacolumn has been reported to be effective as induction therapy in ulcerative colitis (UC). However, the effects of GMA on serial changes in cytokine levels have not been well characterized. We therefore, investigated cytokine levels in UC patients before and after treatment with GMA. A total of 16 patients with active UC, 10 men, and six women, mean age, 42.6 years were included. Fourteen patients had total colitis and two patients had left-sided colitis. The study included nine patients with a chronic intermittent course, six with a chronic continuous course and one with a single episode. The duration of each GMA session was 60 min at a flow rate of 30 mL/min as per study protocol. Serum levels of 17 cytokines were determined simultaneously using a Bio-Plex suspension array system before and after treatment with GMA. Serum interleukin (IL)-10 and macrophage inflammatory protein-1 beta levels were increased significantly in UC patients after GMA treatment compared to pre-treatment levels (P < 0.05). In particular, GMA treatment caused a significant increase in serum IL-10 levels compared to pre-treatment in patients with total colitis or with a chronic intermittent UC course. In conclusion, this investigation showed that GMA was associated with a marked increase in serum level of the anti-inflammatory cytokine, IL-10. The rise in circulating IL-10 is interesting, and potentially a significant factor in the efficacy of GMA in patients with inflammatory bowel diseases. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:146 / 150
页数:5
相关论文
共 50 条
  • [21] An evaluation or therapeutic efficacy and steroid-sparing effect of granulocyte and monocyte adsorptive apheresis in patients with active ulcerative colitis
    Kanke, K
    Nakano, M
    Tominaga, K
    Yoshida, K
    Suzuki, Y
    Ishida, M
    Masuyama, H
    Hiraishi, H
    Terano, A
    Saniabadi, AR
    Shima, C
    GASTROINTESTINAL ENDOSCOPY, 2003, 57 (05) : AB216 - AB216
  • [22] Report on the clinical efficacy and steroid sparing effect of granulocyte and monocyte adsorptive apheresis in patients with corticosteroid dependent ulcerative colitis
    Hanai, H
    Takeuchi, K
    Iida, T
    Tozawa, K
    Tanaka, T
    Saniabadi, A
    Watanabe, F
    Maruyama, Y
    Matsushita, I
    Yamada, M
    Kikuchi, K
    GUT, 2003, 52 : A62 - A63
  • [23] Evaluations of clinical efficacy and steroid sparing effect of granulocyte and monocyte adsorptive apheresis in patients with corticosteroid dependent ulcerative colitis
    Hanai, H
    Takeuchi, K
    Iida, T
    Tozawa, K
    Matsushita, I
    Tanaka, T
    Sato, Y
    Kikuti, K
    Nakamura, T
    Maruyama, Y
    Saniabadi, A
    GASTROENTEROLOGY, 2003, 124 (04) : A518 - A518
  • [24] Daily granulocyte and monocyte adsorptive apheresis in patients with active ulcerative colitis: a prospective safety and feasibility study
    Takayuki Yamamoto
    Satoru Umegae
    Koichi Matsumoto
    Journal of Gastroenterology, 2011, 46
  • [25] Daily granulocyte and monocyte adsorptive apheresis in patients with active ulcerative colitis: a prospective safety and feasibility study
    Yamamoto, Takayuki
    Umegae, Satoru
    Matsumoto, Koichi
    JOURNAL OF GASTROENTEROLOGY, 2011, 46 (08) : 1003 - 1009
  • [26] Granulocyte and monocyte adsorptive apheresis in a case with severe ulcerative colitis unresponsive to conventional medication
    Suzuki, Y
    Yoshimura, N
    Saitoh, Y
    Saniabadi, AR
    JOURNAL OF CLINICAL APHERESIS, 2003, 18 (01) : 40 - 42
  • [27] Potential role of granulocyte/monocyte adsorptive apheresis for ulcerative colitis with concomitant CMV infection
    Nakase, H.
    Matsuura, M.
    Chiba, T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (04) : 497 - 498
  • [28] Intensive granulocyte-monocyte adsorptive apheresis twice a week for treatment of ulcerative colitis
    Tanaka, Hiroki
    Yamashita, Masaki
    Ishii, Manabu
    Motoya, Satoshi
    Imamura, Akimichi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 160 - 160
  • [29] Combination Therapy With Ustekinumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis
    Tanida, Satoshi
    Ozeki, Keiji
    Kanno, Takuya
    Katano, Takahito
    Sugimura, Naomi
    Nishie, Hirotada
    Iwasaki, Hiroyasu
    Tanaka, Mamoru
    Shimura, Takaya
    Kubota, Eiji
    Kataoka, Hiromi
    JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA, 2021, 13 (10-11): : 510 - 514
  • [30] Adsorptive Granulocyte and Monocyte Apheresis in the Treatment of Ulcerative Colitis: The First Multicenter Study in China
    Lai, Ya-Min
    Yao, Wei-Yan
    He, Yao
    Jiang, Xuan
    Gu, Yu-Bei
    Chen, Min-Hu
    Liu, Yu-Lan
    Yuan, Yao-Zong
    Qian, Jia-Ming
    GUT AND LIVER, 2017, 11 (02) : 216 - 225